TRPV4 and bronchopulmonary dysplasia: Although TRPV4 inhibitors could be a promising therapeutic strategy for the treatment of BPD in premature infants, more studies are necessaries to carefully evaluate the potential side effects related to their contribution to calcium signaling in normal fetal lung development.